These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 15799405)

  • 41. Leflunomide: a novel disease modifying anti-rheumatic drug.
    Kale VP; Bichile LS
    J Postgrad Med; 2004; 50(2):154-7. PubMed ID: 15235221
    [No Abstract]   [Full Text] [Related]  

  • 42. How is it best to treat early rheumatoid arthritis patients?
    O'Dell JR
    Best Pract Res Clin Rheumatol; 2001 Mar; 15(1):125-37. PubMed ID: 11358419
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Leflunomide-associated weight loss in rheumatoid arthritis.
    Coblyn JS; Shadick N; Helfgott S
    Arthritis Rheum; 2001 May; 44(5):1048-51. PubMed ID: 11352235
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Rheumatoid arthritis drugs show promise.
    Mayo Clin Health Lett; 1999 Jan; 17(1):4. PubMed ID: 9919935
    [No Abstract]   [Full Text] [Related]  

  • 45. Rheumatoid arthritis. New disease-modifying and anti-inflammatory drugs.
    Infante R; Lahita RG
    Geriatrics; 2000 Mar; 55(3):30-2, 35-6, 39-40. PubMed ID: 10732003
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Clinical therapeutics.
    Robinson DR
    Curr Opin Rheumatol; 1999 May; 11(3):159-60. PubMed ID: 10328572
    [No Abstract]   [Full Text] [Related]  

  • 47. Leflunomide-induced aseptic meningitis.
    Cohen JD; Jorgensen C; Sany J
    Joint Bone Spine; 2004 May; 71(3):243-5. PubMed ID: 15182800
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Leflunomide: mode of action in the treatment of rheumatoid arthritis.
    Breedveld FC; Dayer JM
    Ann Rheum Dis; 2000 Nov; 59(11):841-9. PubMed ID: 11053058
    [TBL] [Abstract][Full Text] [Related]  

  • 49. [Leflunomide-induced toxic epidermal necrolysis].
    El Aïdli S; Salouage I; Kastalli S; Srairi S; Daghfous R; Loueslati MH; Belkahia C
    Therapie; 2008; 63(2):157-8. PubMed ID: 18677817
    [No Abstract]   [Full Text] [Related]  

  • 50. Subacute cutaneous lupus erythematosus associated with leflunomide.
    Elias AR; Tam CC; David-Bajar KM
    Cutis; 2005 Sep; 76(3):189-92. PubMed ID: 16268263
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Leflunomide, mycophenolic acid and matrix metalloproteinase inhibitors.
    Furst DE
    Rheumatology (Oxford); 1999 Nov; 38 Suppl 2():14-8. PubMed ID: 10646484
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Human dihydroorotate dehydrogenase inhibitors, a novel approach for the treatment of autoimmune and inflammatory diseases.
    Leban J; Vitt D
    Arzneimittelforschung; 2011; 61(1):66-72. PubMed ID: 21355448
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Leflunomide: an immunomodulatory drug for the treatment of rheumatoid arthritis and other autoimmune diseases.
    Herrmann ML; Schleyerbach R; Kirschbaum BJ
    Immunopharmacology; 2000 May; 47(2-3):273-89. PubMed ID: 10878294
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Leflunomide-induced acute interstitial pneumonia in a patient treated for rheumatoid arthritis.
    Maskey-Warzęchowska M; Karwat K; Szczepankiewicz B; Langfort R; Szołkowska M; Chazan R
    Pneumonol Alergol Pol; 2015; 83(1):50-4. PubMed ID: 25577534
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Five cases of interstitial lung disease after leflunomide was combined with methotrexate therapy.
    Rutanen J; Kononoff A; Arstila L; Elfving P; Koskela H; Kaipiainen-Seppänen O
    Scand J Rheumatol; 2014; 43(3):254-6. PubMed ID: 24650220
    [No Abstract]   [Full Text] [Related]  

  • 56. Benefit/risk of leflunomide in rheumatoid arthritis.
    Kremer JM; Cannon GW
    Clin Exp Rheumatol; 2004; 22(5 Suppl 35):S95-100. PubMed ID: 15552521
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Innovative treatment approaches for rheumatoid arthritis. Cyclosporin, leflunomide and nitrogen mustard.
    Furst DE
    Baillieres Clin Rheumatol; 1995 Nov; 9(4):711-29. PubMed ID: 8591650
    [TBL] [Abstract][Full Text] [Related]  

  • 58. [Leflunomide in the treatment of rheumatoid arthritis].
    Wendling D
    Ann Med Interne (Paris); 2002 Feb; 153(1):21-4. PubMed ID: 11994686
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Photodistributed eruption with rhabdomyolisis due to leflunomide.
    Adamski H; Lopez L; Polard E; Chevrant-Breton J; Dupuy A
    Photodermatol Photoimmunol Photomed; 2011 Aug; 27(4):222-3. PubMed ID: 21729173
    [No Abstract]   [Full Text] [Related]  

  • 60. Leflunomide-associated skin ulceration.
    McCoy CM
    Ann Pharmacother; 2002 Jun; 36(6):1009-11. PubMed ID: 12022903
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.